Renaissance Technologies (RenTech)'s TBPH Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 127,916 shares of Theravance Biopharma, Inc. (TBPH) worth $2.08 M, representing 0.00% of the portfolio. First purchased in 2014-Q4, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in TBPH, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2015, adding 263,816 shares. Largest reduction occurred in Q3 2015, reducing 263,816 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Theravance Biopharma (TBPH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Theravance Biopharma (TBPH) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +127,916 | New Buy | 127,916 | $16.23 |
| Q1 2023 | -176,426 | Sold Out | 0 | $0.00 |
| Q4 2022 | +24,249 | Add 15.93% | 176,426 | $0.01 |
| Q3 2022 | +152,177 | New Buy | 152,177 | $10.14 |
| Q1 2020 | -17,003 | Sold Out | 0 | $0.00 |
| Q4 2019 | +17,003 | New Buy | 17,003 | $25.88 |
| Q2 2018 | -40,300 | Sold Out | 0 | $0.00 |
| Q1 2018 | +40,300 | New Buy | 40,300 | $24.24 |
| Q1 2016 | -10,880 | Sold Out | 0 | $0.00 |
| Q4 2015 | +10,880 | New Buy | 10,880 | $16.36 |
| Q3 2015 | -263,816 | Sold Out | 0 | $0.00 |
| Q2 2015 | +263,816 | New Buy | 263,816 | $13.02 |
| Q1 2015 | -14,086 | Sold Out | 0 | $0.00 |
| Q4 2014 | +14,086 | New Buy | 14,086 | $14.91 |
Renaissance Technologies (RenTech)'s Theravance Biopharma Investment FAQs
Renaissance Technologies (RenTech) first purchased Theravance Biopharma, Inc. (TBPH) in Q4 2014, acquiring 14,086 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Theravance Biopharma, Inc. (TBPH) for 14 quarters since Q4 2014.
Renaissance Technologies (RenTech)'s largest addition to Theravance Biopharma, Inc. (TBPH) was in Q2 2015, adding 263,816 shares worth $3.44 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 127,916 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $2.08 M.
As of the Q1 2026 filing, Theravance Biopharma, Inc. (TBPH) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Theravance Biopharma, Inc. (TBPH) was 263,816 shares, as reported at the end of Q2 2015.